Trials / Recruiting
RecruitingNCT05521711
TRADE Trial - Tree Nut Immunotherapy Route Development and Evaluation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Hamilton Health Sciences Corporation · Academic / Other
- Sex
- All
- Age
- 1 Year – 16 Years
- Healthy volunteers
- Accepted
Summary
Tree nut immunotherapy Route Assessment and DEvelopment (TRADE) is a randomized controlled trial that evaluates the efficacy and safety of sublingual immunotherapy and lower, more tolerable, doses of oral immunotherapy than currently in use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Food | Commercially available powders or liquids |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2026-11-01
- Completion
- 2027-01-01
- First posted
- 2022-08-30
- Last updated
- 2024-06-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05521711. Inclusion in this directory is not an endorsement.